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Background: Urticarial Vasculitis (UV) is in most of the cases idiopathic; however it has been associated with several
conditions and drugs. Over the counter (OTC) diet pills are widely available, even on-line, but they are rarely regulated
by pharmaceutical control.
Case presentation: We present the case of a 35-year-old female patient suffering of pruriginous and painful wheals
more than 1 cm in diameter, with a burning sensation. The eruption lasted more than 24 hours and was accompanied
by angioedema, headache and myalgia. No remarkable medical history was found, except for previous intake of OTC
diet pills. UV diagnosis was confirmed by the skin biopsy of a lesion.
Conclusion: OTC diet pills are widely available worldwide, and due to its widespread use, allergologists and
dermatologist should be able to recognize symptoms and lesions of cutaneous vasculitis, which may be
under reported.
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The majority of cases of Urticarial Vasculitis (UV) are
idiopathic; however it has been associated with many
different disorders such as infections, connective tissue
diseases, malignancies and also drugs [1]. UV lesions
persist for 24 hours or more and can cause pruritus but
are more commonly painful, with stinging or burning
sensation, and leave a faint residual hyperpigmentation.
Extra-cutaneous manifestations include arthralgia, ab-
dominal pain, obstructive lung disease, nephritis, and
uveitis [2]. Histological criteria for the diagnosis of UV
include nuclear debris or fibrin deposits, with or without
extravasation of red blood cells [3].
A large number of weight-loss pills are available (OTC).
Even more options can be acquired on line. Some of them
report dangerous side effects but, being marketed as a
supplement rather than a drug, these pills are not subject
to rigorous standards of quality control by an agency.* Correspondence: ivancherrez@gmail.com
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A 35 year old woman with a history of intermittent rhin-
itis presented with a 5 day history of urticaria, fever, head-
aches, myalgia and arthralgia. She developed hives and
erythematous maculae in her trunk, back, abdomen and
limbs (Figures 1, 2); they were pruriginous and painful,
with a burning sensation, and had more than 1 cm in
diameter. The lesions lasted more than 24 hours, altering
the pigmentation of the area. Angioedema was present in
hands, fingers, ankles and feet, and left no pitting.
Severe headaches and myalgia impaired the patient’s
ability to conduct her daily routine and fever spiked as
high a 39.5 C.
The patient had been taking OTC diet pills eighteen days
before, and six days previously consulted for dehydration
and violaceous hives in her palms; after that she suspended
the pills.
Physical examination revealed large confluent areas of
wheals and maculae in her trunk, limbs and abdomen,
scored 6/10 in intensity of the pruritus by the patient,
whom also complained of muscular pain. The rest of
the examination was unremarkable. She had a normal
hemoglobin concentration and lymphopenia. The
C-reactive protein concentration was 7.5 mg/Lal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Wheals and erythematous maculae in trunk, back and
abdomen were found.
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function test, urea and creatinine, plasma sodium, glu-
cose and thyroid hormones and antibodies were within
normal ranges. Antinuclear antibodies (ANA) were
not detectable in blood.
The skin biopsy of one lesion was performed, in which a
slight alteration of vacuolar interface was observed, the
papillary dermis presented edema and there was a moder-
ate superficial and perivascular infiltrate of lymphocytes
and eosinophils with focal fibrin deposits in blood vessel
walls and extravasation of erythrocytes. After confirmation
of the diagnosis of UV, the patient was prescribed with oralFigure 2 Wheals and erythematous maculae also can be found
in ankle.corticosteroids and antihistamines, achieving rash remis-
sion. Due to persistence of headaches, fever and myalgia,
hydroxychloroquine was added to the treatment, with
remission of all the symptoms one month later.
Discussion about UV
UV is a condition that usually presents itself with wheals in
the proximal areas of the limbs and in the trunk, often
more painful than pruriginous, with a duration of symp-
toms of more than 24 hours, a violaceous shade to the
lesions, and residual pigmentation after resolution [4]. Two
forms have been described: hypo-complementemic UV and
normo-complementemic UV. The hypo-complementemic
form may as well manifest with or without systemic
symptoms [2].
UV is in most of the cases idiopathic, but there is a wide
variety of conditions, such as infections, hematologic
disorders, physical urticaria, exercise, drugs, etc., that have
been associated with this disease. The most commonly
linked disorders are connective tissue diseases, particularly
SLE and Sjögren’s syndrome. UV is thought to represent a
type III hypersensitivity reaction due to the circulation
immune complexes that may be found in up to 75% of
patients [5].
UV lesions damage the capillary and post-capillary
venules. Histopathological findings include perivascular
neutrophilic or lymphocytic infiltrates with fibrinoid
necrosis, evidence of fully developed leukocytoclastic
vasculitis with injury and swelling of the nuclei of
endothelial cells of postcalpillary venules and extravasation
of erythrocytes [6].
Lymphocytes can predominate or be the only cell ob-
served in older vasculitic lesions. Fibrinoid changes or ne-
crosis and particularly thrombosis are less common in UV
than in the fully developed lesions of palpable purpura.
There is usually little vessel wall disruption and only a
mild degree of perivascular infiltrate, without red blood
cell extravasation, in young UV lesions. Such lesions can
be difficult to distinguish from true urticarial [2].
In our case report, the ingredients in the OTC diet pills
were: synephrine HCL, synthetic 99% guggulsterones, thy-
roid stimulating matrix, Yohimbine HCL and phenylamine.
The unregulated use of synephrine in dietary supple-
ments is arising controversy in the scientific community,
namely regarding to its safety and efficacy when it is
used in weight-loss products [7]. It is well known that
the occurrence of severe cardiovascular toxicity related
to the consumption of synephrine-containing products
determined the temporary prohibition of synephrine in
dietary products in Canada [8].
Yohimbine substantially increases the incidence of ad-
verse drug side effects such as: gastrointestinal discom-
fort (46%), tachycardia (43%), anxiety/agitation (33%),
and hypertension (25%). Yohimbine exposures were
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adverse reactions to drugs, and were more likely to
require management at a health-care facility (odds ratios
[95% CIs] were 5.81 [4.43 to 7.64] and 2.35 [1.82 to
3.04], respectively [9]. Guggulsterones have been associ-
ated with fulminant hepatic failure, requiring emergency
liver transplants [10].
Although all of these ingredients have reported
adverse side effect, this may be the first report of them
inducing vasculitis. We believe that the development of
UV might have been induced by the use of diet OTC
pills, based on the temporal relationship between the
intake of the pills and the appearance of the
dermatological lesions and systemic manifestations in
the lack of another trigger. The histologically proven
vasculitis and finally the reversal of the clinical signs
after discontinuation of the OTC diet pills also suggest
an association.
UV is a manifestation of inflammatory injury of capil-
laries and post-capillary venules in the skin. The ingredi-
ents found in these OTC diet pills have the capacity of
inducing IgG antibodies against the collagen-similar
regions of C1q to form immune complexes, initiating an
inflammatory cascade that leads to mast cell degranula-
tion. The substances released thereby result in increased
vascular permeability causing urticaria and/or angio-
edema [2].
In our center, we have seen several patients who were
using the same diet pills and developed urticaria, but
ethical considerations prevent the conduction of a chal-
lenge test to confirm the association, due to the unpre-
dictability of side effects that may occur on patients.
Conclusions
Several weight loss pills are freely available both OTC
and online. Most have not been proved effective and
some may contain dangerous substances that can cause
life-threatening side effects. UV has been reported in as-
sociation with a large amount of drugs, but this might
be the first report to link UV with use of OTC diet pills.
Given the widespread use of OTC diet pills, allergolo-
gists and dermatologists should be able to recognize cu-
taneous vasculitis, which may be under reported.
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